Delivery Order SPE2DB20D3103-SPE2DB21FQ3U4

Award Date 9/21/21
Potential Completion Date 9/22/21
Potential Value $4.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Cosentyx Sensoready 150 mg pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,522.19, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.28, is for the delivery of Cosentyx 300 mg dose-2 pens, a specialty medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen medication to the Defense Logistics Agency (DLA). The contract, valued at $20,655.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
This federal contract award is for the delivery of Cosentyx 300 mg dose injectable medication to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,485.09 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 24, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Cosentyx 150 mg/ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $12,175.60, is a firm fixed-price delivery order awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Cosentyx, a 300mg dosage medication, to the Defense Logistics Agency (DLA). The $26,345.88 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen injections to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,131.76 and an ultimate completion date of November 9, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pens to the Defense Logistics Agency (DLA). The $3,136.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through May 25, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 syringes. The $4,767.17 firm fixed-price contract has a completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,644.85 Delivery Order contract is for the supply of Cosentyx 300 mg dose-2 pen syringes, a specialty medication used to treat various medical conditions. The contract has a firm fixed price and an ultimate completion date of August 15, 2022. This award is associated with a larger $999,999,999 Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FQ3U4
    Delivery Order

The federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen syringes by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the Defense Logistics Agency (DLA). The $4,411.50 delivery order is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. This IDC is the primary vehicle for Amerisourcebergen to deliver essential medications, devices, and other medical commodities to DLA facilities worldwide. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and its parent company is Cencora, Inc., which does business as Amerisourcebergen. This contract supports the DLA's mission to provide medical supplies and services to the Department of Defense.

Generated 2/27/25, 12:11 PM